Investor profile
SHS Capital has backed 8 European tech companies across 8 funding rounds between 2018 and 2025, joining rounds totalling €127M. Most active in Healthtech and Software. Data as of 6 Aug 2026.
Also recorded as: SHS Ventures
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Salvia BioElectronics | Netherlands | 1 | €53M |
| Dr.Dropin | Norway | 1 | €19M |
| MESI Medical | Slovenia | 1 | €18M |
| PathoQuest | France | 1 | €15M |
| Simulands | Switzerland |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Salvia BioElectronics | Series B | €53M | 2025-05 |
| Dr.Dropin | Other | €19M | 2022-04 |
| MESI Medical | Other | €18M | 2023-06 |
| PathoQuest |
| 1 |
| €10M |
| Selfapy | Germany | 1 | €7.0M |
| Incision | Netherlands | 1 | €5.0M |
| Rhebo | Germany | 1 | €0 |
| Series B |
| €15M |
| 2021-11 |
| Simulands | Other | €10M | 2023-03 |
| Selfapy | Other | €7.0M | 2023-02 |
| Incision | Other | €5.0M | 2021-05 |
| Rhebo | Other | €0 | 2018-02 |
